Author:
Lara Baldomero,Gandı́a Luis,Torres Andrés,Olivares Román,Martı́nez-Sierra Rafael,Garcı́a Antonio G,López Manuela G
Reference30 articles.
1. Agut, J.A., A. Sacristán and J.A. Ortı́z, 1990, Dotarizine: action on 5-HT2 receptor binding in rat frontal cortex, Eur. J. Pharmacol. 183, 2147.
2. Albillos, A., A.G. Garcı́a, B. Olivera and L. Gandı́a, 1996, Re-evaluation of the P/Q Ca2+ channel components of Ba2+ currents in bovine chromaffin cells superfused with low and high Ba2+ solutions, Pflügers Arch. Eur. J. Physiol. 432, 1030.
3. Binnie, C.D., F. De Beukelaar, J.W.A. Meijer, H. Meinardi, J. Overweg, A. Wauquier and A. Van Wieringen, 1985, Open dose ranging trial of flunarizine as add-on therapy in epilepsy, Epilepsia 26, 424.
4. Borges, R., F. Sala and A.G. Garcı́a, 1986, Continuous monitoring of catecholamine release from perfused cat adrenals, J. Neurosci. Methods 16, 389.
5. Brasó, A., C. Cartheuser, A. Sacristán, and J.A. Ortı́z, 1989, Dotarizine, a promising N-benhydryl-piperazine for migraine prophylaxis due to an additional antiserotoninergic effect. 4th Int. Symp. Calcium Antagonists, Pharmacol. Clin. Res., Florence, May 25–27, p. 261.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献